Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in …
YW Liu, YH Yen, WF Li, CC Wang, SN Lu, KM Kee… - Surgical Oncology, 2022 - Elsevier
Background & aims The outcomes of minimally invasive surgery (MIS) vs. percutaneous
radiofrequency ablation (RFA) in treating early-stage hepatocellular carcinoma (HCC) …
radiofrequency ablation (RFA) in treating early-stage hepatocellular carcinoma (HCC) …
Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods
MJ Kuo, LR Mo, CL Chen - BMC cancer, 2021 - Springer
Background We quantified the elusive effects of putative factors on the clinical course of
early hepatocellular carcinoma (HCC) after primary surgical or nonsurgical curative …
early hepatocellular carcinoma (HCC) after primary surgical or nonsurgical curative …
A multicenter nonrandomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF cohort trial).
R Tateishi, K Hasegawa, Y Kawaguchi, T Takayama… - 2020 - ascopubs.org
4581 Background: In parallel with a multicenter randomized controlled trial that reported an
equal recurrence-free survival (RFS) of early-stage hepatocellular carcinoma (HCC) patients …
equal recurrence-free survival (RFS) of early-stage hepatocellular carcinoma (HCC) patients …
First-line systemic treatment strategies for unresectable hepatocellular carcinoma: a systematic review and network meta-analysis of randomized clinical trials
W Liu, B Quan, S Lu, B Tang, M Li, R Chen… - Frontiers in …, 2021 - frontiersin.org
Objective Several new first-line treatments were recently approved for unresectable
hepatocellular carcinoma (HCC). In this meta-analysis, we compare the efficacy and safety …
hepatocellular carcinoma (HCC). In this meta-analysis, we compare the efficacy and safety …
Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10 …
L Yan, Y Ren, K Qian, X Kan, H Zhang, L Chen… - BMC …, 2021 - Springer
Background Transarterial chemoembolization (TACE) and radiofrequency ablation (RFA)
are effective treatment methods for unresectable hepatocellular carcinoma (HCC). However …
are effective treatment methods for unresectable hepatocellular carcinoma (HCC). However …
A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
N Izumi, K Hasegawa, Y Nishioka, T Takayama… - 2019 - ascopubs.org
4002 Background: Surgery (SUR) and radiofrequency ablation (RFA) are both known to be
effective therapy for treating patients with small oligonodular hepatocellular carcinoma …
effective therapy for treating patients with small oligonodular hepatocellular carcinoma …
[HTML][HTML] Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
T Torimura, H Iwamoto - Clinical and Molecular Hepatology, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is usually accompanied by chronic liver damage, which
sometimes influences the selection of HCC treatment. The Barcelona Clinic Liver Cancer …
sometimes influences the selection of HCC treatment. The Barcelona Clinic Liver Cancer …
[HTML][HTML] Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma
JJ Urquijo-Ponce, C Alventosa-Mateu… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a high mortality neoplasm which usually appears on a
cirrhotic liver. The therapeutic arsenal and subsequent prognostic outlook are intrinsically …
cirrhotic liver. The therapeutic arsenal and subsequent prognostic outlook are intrinsically …
A systematic assessment of the quality of systematic reviews/meta‐analyses in radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma
Y Wang, Q Luo, Y Li, S Deng, X Li… - Journal of Evidence …, 2014 - Wiley Online Library
Abstract Objectives The systematic reviews (SRs) of radiofrequency ablation (RFA) versus
hepatic resection (HR) for early hepatocellular carcinoma (HCC) are increasing with varies …
hepatic resection (HR) for early hepatocellular carcinoma (HCC) are increasing with varies …
Optimizing survival and the changing landscape of targeted therapy for intermediate and advanced hepatocellular carcinoma: a systematic review
H Lim, R Ramjeesingh, D Liu, VC Tam… - JNCI: Journal of the …, 2021 - academic.oup.com
Background: Systemic therapy for hepatocellular carcinoma (HCC) consisting of the tyrosine
kinase inhibitor sorafenib has remained unchanged for over a decade, although results from …
kinase inhibitor sorafenib has remained unchanged for over a decade, although results from …